S Velbri

701 total citations
2 papers, 25 citations indexed

About

S Velbri is a scholar working on Immunology, Genetics and Infectious Diseases. According to data from OpenAlex, S Velbri has authored 2 papers receiving a total of 25 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Immunology, 1 paper in Genetics and 0 papers in Infectious Diseases. Recurrent topics in S Velbri's work include Immunodeficiency and Autoimmune Disorders (2 papers), Genomic variations and chromosomal abnormalities (1 paper) and Genetics and Neurodevelopmental Disorders (1 paper). S Velbri is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (2 papers), Genomic variations and chromosomal abnormalities (1 paper) and Genetics and Neurodevelopmental Disorders (1 paper). S Velbri collaborates with scholars based in Sweden, Estonia and United States. S Velbri's co-authors include Karin Roesch, J Zeman, Hana Hansíková, Jan Hadač, Smith Rjh, Aleš Janda, Takeshi Futatani, Anna Asplund, Hans D. Ochs and Anna Šedivá and has published in prestigious journals such as Journal of Clinical Immunology and PubMed.

In The Last Decade

S Velbri

2 papers receiving 25 citations

Peers

S Velbri
Comparison fields: 5 of 19
  • Molecular Biology 12
  • Genetics 12
  • Immunology 10
  • Genetics 6
  • Cellular and Molecular Neuroscience 4
Replace Mattias Forsberg with:
Mattias Forsberg Sweden
AA Roger Thompson United Kingdom
Stefano Onano Italy
Tanja Klein‐Rodewald Germany
Thais S. Rizzi Netherlands
Lamu Gusang China
Lyam Vazquez United States
S. S. Gambarov Russia
Andrew Rupert United States
Abolfazl Heidari Iran
Mattias Forsberg Sweden View profile →
Citations per field, relative to S Velbri
S Velbri · 1×
Citations per year, relative to S Velbri
S Velbri · 1×

Countries citing papers authored by S Velbri

Since Specialization
Citations

This map shows the geographic impact of S Velbri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Velbri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Velbri more than expected).

Fields of papers citing papers by S Velbri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Velbri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Velbri. The network helps show where S Velbri may publish in the future.

Co-authorship network of co-authors of S Velbri

This figure shows the co-authorship network connecting the top 25 collaborators of S Velbri. A scholar is included among the top collaborators of S Velbri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Velbri. S Velbri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
# Work Indexed citations
1 24
2
[Simultaneous determination of the level of immune complexes and immunoglobulins for characterization of the pathologic process].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026